Trial Profile
Retrospective, single-institution study evaluating the effectiveness of MESNA usage on residual cholesteatoma rates in patients who underwent surgery for chronic otitis media with cholesteatoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Mesna (Primary)
- Indications Otitis media
- Focus Therapeutic Use
- 04 Dec 2015 New trial record